![Preview image of Quarterly statement 9 months 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quartely_statement_9m2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Quarterly statement 9 months 2024/25")
![Preview image of Half-year financial report 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_half_year_report_2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Half-year financial report 2024/25")
![Preview image of Quarterly statement 3 months 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quartely_statement_3m2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Quarterly statement 3 months 2024/25")
![Preview image of Annual report 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_annual_report_202425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Annual report 2024/25")
![Preview image of Annual financial statements HGB 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_annual_financial_statements_hgb_2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Annual financial statements HGB 2024/25")
![Preview image of Non-financial report 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_non-financial_report_2425.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Non-financial report 2024/25")
![Preview image of Statement of comprehensive income 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/2_statement_of_comprehensive_income_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of comprehensive income 2024/25")
![Preview image of Income statement 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_income_statement_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Income statement 2024/25")
![Preview image of Statement of financial position 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_statement_of_financial_position_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of financial position 2024/25")
![Preview image of Statement of cash flows{(/)}2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/5_statement_of_cash_flows_2425.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of cash flows{(/)}2024/25")
![Preview image of Statement of comprehensive income 6m 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/en_ger_31032025.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of comprehensive income 6m 2024/25")
![Preview image of Income statement 6m 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/en_guv_31032025.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Income statement 6m 2024/25")
![Preview image of Statement of financial position 6m 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/en_bilanz_31032025.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of financial position 6m 2024/25")
![Preview image of Statement of cash flows {(/)}6m 2024/25]({"max":"/content/dam/med-ag/investor-relations/financial-publications/en_cashflow_31032025.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of cash flows {(/)}6m 2024/25")
![Preview image of Statement of comprehensive income 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/2_statement_of_comprehensive_income_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of comprehensive income 2023/24")
![Preview image of Income statement 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_income_statement_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Income statement 2023/24")
![Preview image of Statement of financial position 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_statement_of_financial_position_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of financial position 2023/24")
![Preview image of Statement of cash flows 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/5_statement_of_cash_flows_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of cash flows 2023/24")
|
2024/25
|
2023/24
|
2022/23
|
||||
|---|---|---|---|---|---|---|
|
|
€m |
% |
€m |
% |
€m |
% |
|
Revenue |
2.227,6 |
100 |
2.066,1 |
100Â Â |
2.089,3 |
100 |
|
Research and development expenses |
326,3 |
14,6 |
343,1 |
16,6 |
349,3 |
16,7 |
EBITA1 |
257,7
|
11,6 |
248,9 |
12,0 |
358,6 |
17,2 |
Consolidated profit |
142,3 |
6,3 |
180,2 |
8,7 |
292,0 |
14,0 |
|
Earnings per share |
1,61 |
2,01 |
3,25 |
|||
|
Dividend per share2 |
0,55 |
0,60 |
1,10 |
|||
|
|
||||||
|
Cash flows from operating activities |
209,9 |
247,3 |
250,9 |
|||
Cash flows from investing activities
|
-91,0 |
-412,3 |
-111,0 |
|||
|
Cash flows from financing activities |
-108,8 |
176,2 |
-135,1 |
|||
|
|
||||||
|
|
30 Sep 2025 |
30 Sep 2024 |
30 Sep 2023 |
|||
Total assets
|
3.403,4 |
100 |
3.393,2 |
100Â Â |
3.032,9 |
100 |
|
Property, plant and equipment |
343,0 |
10,1 |
353,8 |
10,4 |
315,8 |
10,4 |
|
Equity |
2.127,7 |
62,5 |
2.056,5 |
60,6 |
2,172,9 |
71,6 |
|
Net financial debt3 |
-276,9 |
-327,4 |
863,8 |
|||
|
|
||||||
|
|
30 Sep 2025 |
30 Sep 2024 |
30 Sep 2023 |
|||
|
Return on equity |
|
6,6 |
|
8,7 |
|
13,4 |
|
|
||||||
|
|
30 Sep 2025 |
30 Sep 2024 |
30 Sep 2023 |
|||
|
Employees (number) |
5.784 |
5.726 |
4.823 |
|||
![Carl Zeiss Meditec AG]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.100.33.0,80,1684,641.file/screenshot.png","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.360.120.0,80,1684,641.file/screenshot.png","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.768.256.0,80,1684,641.file/screenshot.png","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1024.341.0,80,1684,641.file/screenshot.png","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1280.427.0,80,1684,641.file/screenshot.png","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1440.480.0,80,1684,641.file/screenshot.png","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/screenshot.png/_jcr_content/renditions/original.image_file.1684.561.0,80,1684,641.file/screenshot.png"} "Carl Zeiss Meditec AG")
Annual Report 2024/25
Expanding Markets.
Transforming HealthcareFinancial Publications
New products are the key to our company's success. This innovative strength is the driving force of our growth. In this section we present facts and figures on the company's financial position.Downloads
Key Financial Figures
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1765,992.file/archive.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1765,992.file/archive.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1765,992.file/archive.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1765,992.file/archive.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1280.720.1,0,1765,992.file/archive.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1440.810.1,0,1765,992.file/archive.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1764.992.1,0,1765,992.file/archive.jpg"})
Request investor information
-
1
Earnings before interest, taxes and amortization on intangible assets from purchase price allocations
-
2
Amount proposed by the Supervisory Board and the Management Board of Carl Zeiss Meditec AG
-
3
Fiscal year 2022/23 shows the net liquidity (Cash and cash equivalents plus treasury receivables from/payables to the treasury of Carl Zeiss AG)